NY 11201, USA asymptomatic HIV infection is unlikely, but prospective evaluation of infected individuals with long survivals may yet reveal insidious brain damage if the CNS infection with HIV persists.
If patients are going to develop neurological signs and symptoms after they have other nonneurological manifestations of AIDS, the mean interval to symptom onset is only 5 monthsv'", The CNS manifestations of AIDS which most often antedate other signs and~mptoms of AIDS are psychiatric phenomenal-. Depression, social withdrawal, depressed libido, psychomotor retardation, and obvious personality changes are most common1, 13 .
HIV SUBACUTE ENCEPHALOMYELITIS
HIV in the central nervous system routinely produces a subacute encephalomyelitis, a mildly inflammatory demyelinating disease of the brain and spinal cord 9 ,14. This disease is most evident as an encephalopathy, a disturbance of brain function often referred to as AIDS-dementia complex 15, 16 . In fact, the most common sign of encephalopathy directly attributable to HIV infection of the brain is dementia. This and other neurological manifestations of AIDS occasionally may antedate all other signs of HIV infection.
Signs and symptoms
If dementia occurs as an early manifestation of CNS disease, it is often overlooked unless it is profound. The dementia that does develop usually involves memoryproblems, disorientation, and mildlanguage disturbances ll • 17 ,18. As eNS damage progresses the patient will exhibit problems with bladder and bowel control, hallucinations, psychomotor retardation, and more global signs of demential.12,13. Poor concentration and blunted affect are usually evident. Gait ataxia and tremor often appear'". The most severely impaired patients have myoclonus, spasticity, seizures, and a frank psychosis. All patients eventually develop some type of motor or coordination disturbance, the most common being paraparesis, tremors and ataxia. Rigidity, chorea, and even segmental d:lstonias, such as torticollis, develop in many19, . Death does not result from neurological disease except indirectly21,22. The akinetic or paralysed patient is obviously more susceptible to aspiration and other causes of terminal infection than the neurologically intact individual. In fact, patients with prominent neurological disease antedating severe immunodeficiency survive a few months longer than those presenting with immunodeficiency prior to the appearance of neurological problems. Although the evolution of neurological problems usually occurs over the course of months, some individuals will deteriorate over the course of days or weeks.
Painful sensory neuropathy may antedate central nervous system manifestations of AIDS, but HIV encephalopathy with dementia usually does develop first 23. Other central nervous system problems directly attributable to HIV include a viral meningitis and a Guillain-Barre syndrome. Although only 10% of patients with HIV infection exhibit HIV meningitis, more than 90% usually have evidence of mv encephalopathy at autopsy1,7,23.
Pathophysiology CNS involvement with HIV may occur before substantial immunodeficiency occurs10,17,18. How the virus crosses the blood-brain barrier and establishes itself in the brain is still uncertain. Infected monocytes or macrophages are presumed to carry the HIV across the blood-brain barrier, but viral antigen has been found in endothelial cells, as well as in macrophages and macrophage-derived cells 2 4-26. This leaves open the possibility that HIV gets into the CNS by first infecting endothelial cells and then breaching the blood-brain barrier when these cells are impaired. Even after the CNS has been infected by the virus, the interval is variable before HIV encephalomyelitis develops. What initiates the encephalopathy and myelitis that ensue and what regulates the pace of deterioration is unknown--",
Diagnostic tests
Brain biopsy is the only way to establish that the patient has an HIV encephalomyelitis's, Other tests are simply not specific enough to make the diagnosis. Whether or not brain biopsy is justifiable in immunosuppressed patients without obvious intracranial masses is controversial. The inherent dangers of a biopsy in a patient with AIDS include the risk of disease spread to the surgeon and the risk of postoperative superinfection of the patient. Until treatment highly effective against HIV encephalomyelitis is available, this dangerously invasive procedure is rarely warranted.
Other diagnostic tests do provide evidence of HIV encephalomyelitis, but none of the tests is specific for this demyelinating disease. The cerebrospinal fluid (CSF) of affected individuals may have a moderate elevation of the total protein content and a low-grade mononuclear pleocytosis, but the CSF profile is otherwise unrevealing 7 ,9,29. HIV antigen and antibodies may be isolated from the CSF of individuals without HIV encephalomyelitiso', The EEG also contributes no confirmatory evidence of the encephalomyelitis since it typically reveals little more than generalized slowing. Magnetic resonance (MR) and computed tomographic (CT)scans of the brain need not reveal any lesion but most do show generalized atrophy. In fact, what most suggests HIV encephalomyelitis in the absence of biopsy confirmation is this unremarkable collection of test results in a patient with AIDS and progressive CNS disease. This is especially true if prominent features of the CNS disease observed include dementia, movement disorders, psychiatric disturbances, and ataxia.
Histopathology
Inflammatory changes in the brain with HIV encephalomyelitis are slight"-14. What is most characteristic of this AIDS encephalopathy is the presence of microglial nodules with multinucleated giant cells. Microglial nodules are clusters of mononuclear cells, which are presumed to have arisen from microglia and macrophages in the brain. The multinucleated giant cells, often called syncytial cells, are presumed to arise from the fusion of several HIV infected macrophagesl-". Alternatively, a single infected macrophage may fuse with many uninfected macrophages and thereby deplete the normal macrophage population in the brain. Neuronal loss is not especially prominent with HIV encephalomyelitis. The neuronal loss that does occur is not associated with the microglial nodules. If there is a characteristic distribution of these scattered nodules, it is that they tend to cluster around blood vessels.
In children with AIDS encephalomyelitis, more than in adults, calcifications often occur in the infected brain1,30,31. These calcifications usually develop in the basal ganglia and perivascularlyl-16.
Focalnecrosis and demyelination are also apparent throughout the brain in both children and adults. Areas of reactive astrocytosis may be apparent. Axonal degeneration may occur in association with this demyelination.
The brainstem, cerebellum, and spinal cord are often less severely involved than the cerebral hemispheres. The myelopathy that develops with mv encephalomyelitis is a demyelinating disorder usually manifested by progressive spastic paraparesis, impaired position and vibration sense, gait ataxia, and incontinence. Vacuolar changes are evident in the myelin sheaths that are affected. This gives the spinal cord a spongy appearance when viewed under the microscope and is consequently called a spongiform myelitis 32 • Neurons in the spinal cord, as in the brain, are generally spared. 
Treatment
The only treatment currently available for HIV su~acute encephalomyelitis is zidovudine (AZT)33,34. This antiretroviral agent reduces the individual's s~sceptibility to opportunistic infections and certainly reduces the incidence of these infections in the CNS, but that it can reverse or arrest the damage done by HIV encephalomyelitis is l~ss certain. Dideoxyinosine (ddI) is another antiylral~rug that inhibits the progression of HIV InfectIon, but that it affects the course of CNS disease associated with HIV infection remains to be established.
OPPORTUNISTIC INFECTIONS
Opportunistic infections develop in the CNS along with or independently of HIV encephalomyelitis. !he responsible organisms range from obligate Intracellular parasites, such as Toxoplasma gondii, to c~mmonly occurring viruses, such as cytomegaloVIrUS (CMV) (see Figure 1) 35. Infections with cryptococcal organisms, nocardia, atypical mycobacteria, tuberculosis, Treponema pallidum, varicellazoster, Epstein-Barr virus, and herpes simplex arẽ specially common'", Identifying the opportunistic Infection that is causing eNS symptoms is complicat~d by the susceptibility of immunodeficient patIents to infection by several different organisms at the same time. In fact HIV encephalomyelitis and multiple opportunistic CNS infections may appear and progress at the same time.
Signs and symptoms
The si 9ns and symptoms of opportunistic infection involVing the CNS are highly variable. Many of the Lechtenberg The immune defect in the CNS alters the pattern of the infections that occasionally appear in immunocompetent individuals. A striking example of this is herpes encephalitis. In the immunodeficient patient this virus does not produce the fulminant haemorrhage temporal lobe lesion characteristic of the immunocompetent patient. Damage from the virus is more diffuse, with inflammatory changes developing much more slowly and less dramatically than in the immunocompetent host. Apparently, much of the damage done in the conventional herpes encephalitis is from a self-destructive reaction of the immune system to the virus.
Diagnostic tests
The conventional methods for identifying infectious agents in the CNS may be ineffective in immunodeficient patients. Antibody titres for toxoplasmosis, cytomegalovirus, and herpes may change inconsistently or not at all despite fulminant disease 35 ,37,38. Mycobacterial skin tests will be unreactive if the patient is anergic. Efforts to isolate the responsible organism from the CSF may be unsuccessful except with routine fungi and bacteria 36 ,39. Even with cryptococcal and mycobacterial infections, the responsible organism may be difficult to culture.
The most reliable method for identifying the cause of an opportunistic infection is biopsy of the part "--------------------------------------- of the brain most obviously involved. Many of these opportunistic infections produce discrete masses in the brain which may be approached with stereotactic or conventional neurosurgical techniques. Because brain biopsy is a relatively traumatic procedure" even in the best of hands, many neurologists prefer to initiate therapeutic trials before resorting to surgery. The drugs used will be dictated by the appearance of the lesion on neuroimaging studies and results of noninvasive efforts to identify the organism.
Neuroimaging studies are usually helpful in limiting the probable causes of the CNS lesiorr'". A ring enhancing lesion on CT or MR scanning is most likely to be a granuloma, abscess, or tumor. Although CNS cytomegalovirus, nocardia, or lymphoma may produce this pattern, ToxopJasma granulomas or abscesses are more likel}" '5.41,42. Toxoplasma granulomas are especially likely in the frontoparietal areas and are often multiple 37,43. These lesions may have calcificationsin or about the area of ring enhancement on CT scanning.
Histopathology
For many of the opportunistic infections, the most significant change in the brain tissue is the presence of the organism itself. Special stains may be necessary to identify the responsible organism, but most of those occurring as opportunistic infections with AIDS are identifiable with fairly conventional techniques. Filaments associated with fungi may be prominent on routine tissue sections. Peroxidaseantiperoxidase staining will reveal the Toxoplasma gondii even if discrete cysts or pseudocysts are not apparentt-". Viruses are more difficult to identify, but characteristic tissue changes help to limit the spectrum of probable agents in the HIV-infected patient.
With CMV infection, demyelination, neuronal loss, and gliosis develop in the brain, but none of these is specific for this viral disorder. What helps establish CMV as the responsible organism is a distinctive distribution of microglial nodules and characteristic inclusion bodies in injured cells. The microglial nodules develop subependymally and are not associated with syncytial cells. The inclusion bodies developing in greatly enlarged cells are both intranuclear and intracytoplasmic. Antibody probes for CMV DNA will establish that the inclusion bodies in these cells are from CMV.
Opportunistic infections which are especially difficult to distinguish from HIV encephalomyelitis are those caused by some varieties of papova- encephalomyelitis are not evident. In PML, giant astrocytes are found in and about the areas of demyelination. Oligodendroglial cells, the cells responsible for producing and maintaining the myelin sheaths in the brain, have swollen nuclei and large inclusion bodies". Macrophages develop a foamy appearance as they ingest myelin debris (see Figure 2 ). Electron microscopic examination of the brain tissue will even reveal the filamentous papovaviruses responsible for the lesion. When PML is fairly advanced the CT or MR scan may reveal multiple areas of hypodensity corresponding to regions with severe demyelination induced by the viral infection. This pattern is less likely to be apparent with HIV encephalomyelitis and may support the diagnosis of PML without biopsy proof of the diagnosis.
Treatment
Conventional treatment for the infections occurring opportunistically in the CNSof patients with AIDS is appropriate, but may be unsuccessful. Antiviral treatment of Herpes simplex and papovaviruses may be considerably less successful than the management of these same problems in patients without AIDS. Even the penicillin-sensitive T. pallidum may prove fairly refractory to customary doses and durations of treatment. T. pallidum readily invades the CNS and may produce neurosyphilis in its meningovascular or intraparenchymal forms within weeks or months, rather than years or decades 47 ,48 . Because the AIDS patient with syphilis is at high risk of developing neurosyphilis, patients with previously untreated syphilis should be given meningitic doses of penicillin. AIDS patients with CNS cryptococcal infections may respond to treatment with amphotericin-B and 5-fluorocytosine (5-FC), but when treatment is stopped, these patients invariably have recurrent cryptococcal infections. Consequently, weekly treatment with amphotericin-B is essential for the co.ntinued survival of the patient. All AIDS patients with opportunistic infections in the CNS must be managed with HIV suppressants, such as zidovudine and ddI.
PRIMARY BRAIN LYMPHOMA
The incidence of primary brain lymphomas is mordmately increased in patients with AIDS42,49,50. Alth0.ugh other tumours, such as a systemic lymphoma and Kaposi's sarcoma, may metastasize to the brain, the overwhelming majority of intracr~nial neoplasms discovered with AIDS are pnmary brain lymphomas. These tumours develop as discrete masses, rather than as meningeal lymphomatosis, a pattern much more characteristic of systemic lymphomas which spread to the eNS (see Figure 3) . These brain tumours are currently the second most common cause of masses in the brains of patients with AIDSI,5I. Unfortunately, they are difficult to distinguish from Toxoplasma granulomas, the most common cause of brain masses in AIDS patients 50 ,52. Signs and symptoms Patients with these tumours may present with focal motor or sensory deficits or with more generalized cognitive difficulties. Seizures often develop as the first manifestation of the lymphoma, but focal deficits evolve rapidly in some patients who never have seizures'P. Asymptomatic primary brain l:>:mphomas are found at autopsy in some individuals who die from opportunistic infections.
Pathophysiology
Wh,Y this lymphoproliferative disorder develops in patients with immunodeficiency is still unknown. Lechtenberg . AIDS in the brain 315 
Treatment
Once it has been established that the patient has a primary brain lymphoma, whole brain irradiation may be effective in those patients who survive other complications of their immunodeficiency to profit from the treatment. Some physicians use chemotherapy as an adjunct to the radiation therapy but the value of this approach remains to be established.
IMPLICATIONS OF HIV IN THE CNS
AIDS may yet prove manageable with antiviral therapy or other measures which neutralize the systemic effects of the HIVs, but any measure short of preventing HIV infection may leave patients susceptible'to CNS damage from the virus. As we currently understand the brain and spinal cord complications of HIV infection, much of the viral damage appears to be unrelated to immunodeficiency. HIV behaves much like more conventional slow viral diseases of the CNS, even to the point of producing a vacuolar myelopathy. This suggests that, even with correction of the immunological defect induced by HIV, infected individuals will eventually develop a progressive encephalomyelitis with an outcome just as invariably lethal as AIDS.
If HIV subacute encephalomyelitis follows a course similar to that already observed with slow viral illnesses of the CNS, more protracted survival in patients with HIV infection may be expected to produce a progressive and irreversible dementia over the course of months or years. Preventing HIV infection with a vaccine or inactivating the virus in the CNS by whatever means should avert this tragic outcome.
